DSM-Firmenich AG (DSFIR) | Stock Overview & Key Data
DSM-Firmenich AG Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: €124.85 on September 30, 2024
Explore how other NL stocks compare to their 52-week ranges: View NL Market 52-Week Insights
Key Statistics
Financial Highlights
Annual Income Flow
2025
Dividend Information
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
DSM-Firmenich AG
DSFIR
|
16.17B Large-cap | -0.64% | 10.89% | 12.98% | 12.98% | 12.98% | 19.27% | 19.27% | 19.27% | 19.27% | 19.27% | 19.27% |
|
Akzo Nobel N.V
AKZA
|
9.04B Large-cap | 26.50% | 36.15% | 33.92% | 33.92% | 33.92% | 33.78% | 33.78% | 33.78% | 33.78% | 33.78% | 33.78% |
|
IMCD N.V
IMCD
|
5.68B Large-cap | -0.58% | -12.75% | 16.05% | 18.40% | 14.86% | -26.08% | -38.93% | -33.18% | 137.86% | 294.90% | 294.90% |
|
Corbion N.V
CRBN
|
1.07B Large-cap | -3.09% | 3.90% | 3.24% | 4.67% | 5.06% | 5.83% | -21.88% | -57.74% | -9.85% | -15.80% | -9.77% |
|
OCI N.V
OCI
|
766.66M Mid-cap | -1.06% | 3.31% | 5.35% | 11.64% | 21.43% | -51.17% | -82.19% | -83.00% | -70.62% | -90.47% | -90.47% |
|
Avantium N.V
AVTX
|
171.15M Mid-cap | -0.98% | 4.47% | 37.61% | 29.22% | 29.22% | -51.26% | -73.09% | -78.96% | -90.59% | -90.59% | -90.59% |
Ownership & Short Interest
Calculate Your DSM-Firmenich AG Investment Returns
Long-Term Investment Performance Analysis
DSM-Firmenich AG stock price in Mar 2026 was €60.50, A €1,000.00 lump sum investment in DSM-Firmenich AG made 0 years ago would be worth approximately €1,127.60 today, representing a positive return of 12.76%.
2 Months Investment Scenario (Mar 2026 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is DSFIR's 52-week high and low?
- In the last 52 weeks, DSM-Firmenich AG reached a high of €99.40 (on N/A) and a low of €55.22 (on March 12, 2026).
- What is the market cap and P/E ratio for DSFIR?
- Curious about DSM-Firmenich AG's size and valuation? Its market capitalization stands at 16.17B. When it comes to valuation, the P/E ratio (trailing twelve months) is 53.42, and the forward P/E (looking ahead) is 16.15.
- Does DSFIR pay dividends? If so, what's the yield?
- Yes, DSM-Firmenich AG is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 2.63%, and the company has paid an average of €2.20 per share annually over the past 3 years.
- Who are DSM-Firmenich AG's main competitors or similar companies to consider before investing?
When looking at DSM-Firmenich AG, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Akzo Nobel N.V
AKZA9.04B Basic Materials Specialty Chemicals 33.78% 33.78% IMCD N.V
IMCD5.68B Basic Materials Specialty Chemicals -26.08% -38.93% Corbion N.V
CRBN1.07B Basic Materials Specialty Chemicals 5.83% -21.88% OCI N.V
OCI766.66M Basic Materials Specialty Chemicals -51.17% -82.19% Avantium N.V
AVTX171.15M Basic Materials Specialty Chemicals -51.26% -73.09% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for DSM-Firmenich AG? (e.g., ROE, Debt/Equity)
- To get a sense of DSM-Firmenich AG's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 1.66%, the Debt to Equity ratio from the most recent quarter is 28.64, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for DSFIR?
- Looking at DSM-Firmenich AG's growth, its revenue over the trailing twelve months (TTM) was €9B. Compared to the same quarter last year (YoY), quarterly revenue grew by N/A, and quarterly earnings saw a YoY growth of N/A.
- How much of DSFIR stock is held by insiders and institutions?
- Wondering who owns DSM-Firmenich AG stock? Company insiders (like executives and directors) hold about 9.49% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 32.21%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.